Although Sema7A has a stimulating effect on the maturation and antigen presentation of DCs, which is beneficial for immune response, a growing number of studies have shown that Sema7A/integrin β1 is a promigratory signal and confers poor survival rate in glioma and breast cancer (96, 97). The gene discussed is SEMA7A; the disease is central nervous system cancer.